Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome.
|
Diabetes
|
2006
|
1.44
|
2
|
Retracted
Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6.
|
FASEB J
|
2005
|
1.39
|
3
|
Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury.
|
Exp Neurol
|
2003
|
1.16
|
4
|
Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures.
|
J Neurosci Res
|
2005
|
1.08
|
5
|
Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior.
|
Brain Behav Immun
|
2012
|
1.01
|
6
|
Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis.
|
J Neurochem
|
2005
|
0.93
|
7
|
Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
|
J Neurosci Res
|
2003
|
0.91
|
8
|
Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury.
|
J Neurosci Res
|
2005
|
0.90
|
9
|
Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury.
|
J Neurochem
|
2009
|
0.86
|
10
|
Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6.
|
J Neuropathol Exp Neurol
|
2003
|
0.86
|
11
|
Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior.
|
J Neurosci Res
|
2007
|
0.85
|
12
|
Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat.
|
Brain Behav Immun
|
2009
|
0.84
|
13
|
Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury.
|
J Neurosci Res
|
2006
|
0.83
|
14
|
Role of metallothionein-III following central nervous system damage.
|
Neurobiol Dis
|
2003
|
0.83
|
15
|
Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.
|
J Comp Neurol
|
2002
|
0.83
|
16
|
Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
|
J Neurosci Res
|
2004
|
0.82
|
17
|
Analysis of the cerebral transcriptome in mice subjected to traumatic brain injury: importance of IL-6.
|
Neuroimmunomodulation
|
2007
|
0.81
|
18
|
Retracted
Exercise-induced metallothionein expression in human skeletal muscle fibres.
|
Exp Physiol
|
2005
|
0.81
|
19
|
Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
|
Glia
|
2003
|
0.79
|
20
|
Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout mice.
|
J Neurosci Res
|
2006
|
0.78
|
21
|
Obesity and metabolomics: metallothioneins protect against high-fat diet-induced consequences in metallothionein knockout mice.
|
OMICS
|
2015
|
0.78
|
22
|
Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation.
|
Exp Biol Med (Maywood)
|
2006
|
0.77
|
23
|
The comparison of mouse full metallothionein-1 versus alpha and beta domains and metallothionein-1-to-3 mutation following traumatic brain injury reveals different biological motifs.
|
J Neurosci Res
|
2010
|
0.76
|
24
|
Catecholaminergic and cholinergic systems of mouse brain are modulated by LMN diet, rich in theobromine, polyphenols and polyunsaturated fatty acids.
|
Food Funct
|
2015
|
0.76
|
25
|
Metallothionein expression and oxidative stress in the brain.
|
Methods Enzymol
|
2002
|
0.75
|